Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 660

1.

Outcomes and predictors of clinical T1 to pathological T3a tumor up-staging after robotic partial nephrectomy: a multi-institutional analysis.

Gorin MA, Ball MW, Pierorazio PM, Tanagho YS, Bhayani SB, Kaouk JH, Rogers CG, Stifelman MD, Khalifeh A, Kumar R, Sivarajan G, Allaf ME.

J Urol. 2013 Nov;190(5):1907-11. doi: 10.1016/j.juro.2013.06.014. Epub 2013 Jun 11.

PMID:
23764083
2.

Differential use of partial nephrectomy for intermediate and high complexity tumors may explain variability in reported utilization rates.

Lane BR, Golan S, Eggener S, Tobert CM, Kahnoski RJ, Kutikov A, Smaldone M, Whelan CM, Shalhav A, Uzzo RG.

J Urol. 2013 Jun;189(6):2047-53. doi: 10.1016/j.juro.2013.01.007. Epub 2013 Jan 9.

PMID:
23313207
3.

Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.

Yoo C, Song C, Hong JH, Kim CS, Ahn H.

J Urol. 2008 Aug;180(2):486-91; discussion 491. doi: 10.1016/j.juro.2008.04.034. Epub 2008 Jun 11.

PMID:
18550101
4.

Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.

Margulis V, Tamboli P, Matin SF, Meisner M, Swanson DA, Wood CG.

J Urol. 2007 Nov;178(5):1878-82. Epub 2007 Sep 17.

PMID:
17868733
5.

Pathological T3a Upstaging of Clinical T1 Renal Cell Carcinoma: Outcomes According to Surgical Technique and Predictors of Upstaging.

Jeong SH, Kim JK, Park J, Jeon HJ, Yoon MY, Jeong CW, Ku JH, Kim HH, Kwak C.

PLoS One. 2016 Nov 18;11(11):e0166183. doi: 10.1371/journal.pone.0166183. eCollection 2016.

6.

10-year oncologic outcomes after laparoscopic and open partial nephrectomy.

Lane BR, Campbell SC, Gill IS.

J Urol. 2013 Jul;190(1):44-9. doi: 10.1016/j.juro.2012.12.102. Epub 2013 Jan 8.

PMID:
23306087
7.

Partial nephrectomy versus radical nephrectomy for non-metastatic pathological T3a renal cell carcinoma: a multi-institutional comparative analysis.

Oh JJ, Byun SS, Lee SE, Hong SK, Lee ES, Kim HH, Kwak C, Ku JH, Jeong CW, Kim YJ, Kang SH, Hong SH.

Int J Urol. 2014 Apr;21(4):352-7. doi: 10.1111/iju.12283. Epub 2013 Sep 30.

8.

Tumor complexity predicts malignant disease for small renal masses.

Mullins JK, Kaouk JH, Bhayani S, Rogers CG, Stifelman MD, Pierorazio PM, Tanagho YS, Hillyer SP, Kaczmarek BF, Chiu Y, Allaf ME.

J Urol. 2012 Dec;188(6):2072-6. doi: 10.1016/j.juro.2012.08.027. Epub 2012 Oct 18.

PMID:
23083863
9.

Renal cell carcinoma in the solitary kidney: an analysis of complications and outcome after nephron sparing surgery.

Ghavamian R, Cheville JC, Lohse CM, Weaver AL, Zincke H, Blute ML.

J Urol. 2002 Aug;168(2):454-9.

PMID:
12131287
10.

Hilar location is an independent prognostic factor for recurrence in T1 renal cell carcinoma after nephrectomy.

Shim M, Song C, Park S, Kim A, Choi SK, Kim CS, Ahn H.

Ann Surg Oncol. 2015 Jan;22(1):344-50. doi: 10.1245/s10434-014-4153-0. Epub 2014 Oct 17.

PMID:
25323469
11.

Partial nephrectomy for renal masses ≥ 7 cm: technical, oncological and functional outcomes.

Long CJ, Canter DJ, Kutikov A, Li T, Simhan J, Smaldone M, Teper E, Viterbo R, Boorjian SA, Chen DY, Greenberg RE, Uzzo RG.

BJU Int. 2012 May;109(10):1450-6. doi: 10.1111/j.1464-410X.2011.10608.x. Epub 2012 Jan 5.

12.

R.E.N.A.L. nephrometry score in clinical stage T1 renal mass: Ramathibodi hospital experience.

Prasit S, Sirisreetreerux P, Sangkum P, Kijvikai K, Viseshsindh W, Kongchareonsombat W, Leenanupunth C, Kochakarn W.

J Med Assoc Thai. 2015 Feb;98(2):181-7.

PMID:
25842799
13.

Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.

Itano NB, Blute ML, Spotts B, Zincke H.

J Urol. 2000 Aug;164(2):322-5.

PMID:
10893575
14.

7-year oncological outcomes after laparoscopic and open partial nephrectomy.

Lane BR, Gill IS.

J Urol. 2010 Feb;183(2):473-9. doi: 10.1016/j.juro.2009.10.023. Epub 2009 Dec 14.

PMID:
20006866
15.

Functional and oncological outcomes of partial nephrectomy of solitary kidneys.

La Rochelle J, Shuch B, Riggs S, Liang LJ, Saadat A, Kabbinavar F, Pantuck A, Belldegrun A.

J Urol. 2009 May;181(5):2037-42; discussion 2043. doi: 10.1016/j.juro.2009.01.024. Epub 2009 Mar 18.

PMID:
19298974
16.

Significance of Pathologic T3a Upstaging in Clinical T1 Renal Masses Undergoing Nephrectomy.

Ramaswamy K, Kheterpal E, Pham H, Mohan S, Stifelman M, Taneja S, Huang WC.

Clin Genitourin Cancer. 2015 Aug;13(4):344-9. doi: 10.1016/j.clgc.2015.01.001. Epub 2015 Jan 22.

PMID:
25680295
17.

Perioperative morbidity, oncological outcomes and predictors of pT3a upstaging for patients undergoing partial nephrectomy for cT1 tumors.

Mouracade P, Kara O, Dagenais J, Maurice MJ, Nelson RJ, Malkoc E, Kaouk JH.

World J Urol. 2017 Feb 14. doi: 10.1007/s00345-017-2004-x. [Epub ahead of print]

PMID:
28197727
18.

Outcome of laparoscopic radical and open partial nephrectomy for the sporadic 4 cm. or less renal tumor with a normal contralateral kidney.

Matin SF, Gill IS, Worley S, Novick AC.

J Urol. 2002 Oct;168(4 Pt 1):1356-9; discussion 1359-60.

PMID:
12352392
19.

Comparative outcomes and assessment of trifecta in 500 robotic and laparoscopic partial nephrectomy cases: a single surgeon experience.

Khalifeh A, Autorino R, Hillyer SP, Laydner H, Eyraud R, Panumatrassamee K, Long JA, Kaouk JH.

J Urol. 2013 Apr;189(4):1236-42. doi: 10.1016/j.juro.2012.10.021. Epub 2012 Oct 16.

PMID:
23079376
20.

Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.

Badalato GM, Kates M, Wisnivesky JP, Choudhury AR, McKiernan JM.

BJU Int. 2012 May;109(10):1457-62. doi: 10.1111/j.1464-410X.2011.10597.x. Epub 2011 Sep 20.

Supplemental Content

Support Center